Aisling Capital Management LP - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 94 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
Aisling Capital Management LP ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$3,046,340
-8.5%
1,043,2670.0%1.32%
+17.1%
Q1 2024$3,328,022
-5.1%
1,043,2670.0%1.13%
+7.6%
Q4 2023$3,505,377
+41.2%
1,043,2670.0%1.05%
+2.2%
Q3 2023$2,482,975
+35.2%
1,043,2670.0%1.02%
+13.8%
Q2 2023$1,836,150
-42.9%
1,043,2670.0%0.90%
-41.8%
Q1 2023$3,213,262
-41.9%
1,043,2670.0%1.55%
-57.6%
Q4 2022$5,529,315
+50.1%
1,043,2670.0%3.65%
+49.2%
Q3 2022$3,683,000
+36.8%
1,043,2670.0%2.45%
+27.3%
Q2 2022$2,692,000
-42.4%
1,043,2670.0%1.92%
-23.8%
Q1 2022$4,674,000
-34.2%
1,043,2670.0%2.52%
+0.6%
Q4 2021$7,105,000
-6.6%
1,043,2670.0%2.51%
+65.3%
Q3 2021$7,605,000
-27.3%
1,043,2670.0%1.52%
-9.4%
Q2 2021$10,454,000
+4.9%
1,043,2670.0%1.67%
-6.6%
Q1 2021$9,963,000
-12.9%
1,043,2670.0%1.79%
-8.8%
Q4 2020$11,445,000
+23.7%
1,043,2670.0%1.96%
-33.5%
Q3 2020$9,254,0001,043,2672.96%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$11,445,0001.96%
Pentwater Capital Management LP 4,967,227$54,490,0000.66%
SECTORAL ASSET MANAGEMENT INC 838,826$9,202,0000.65%
Vivo Capital, LLC 926,447$10,163,0000.45%
Boxer Capital, LLC 1,251,055$13,724,0000.44%
Ikarian Capital, LLC 250,837$2,752,0000.12%
Perceptive Advisors 787,745$8,642,0000.09%
Rock Springs Capital Management LP 289,754$3,179,0000.07%
Regent Investment Management LLC 20,000$219,0000.06%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,450,268$15,909,0000.04%
View complete list of POSEIDA THERAPEUTICS INC shareholders